Cargando…

Clinical application of (18)F-FCH PET/CT in the diagnosis and treatment of hyperparathyroidism

OBJECTIVE: We evaluated the difference in parathyroid visualization on (18)F-FCH PET/CT images obtained at 5 and 60 min, and quantitatively analyzed the mode of FCH uptake at different time points, to determine the best imaging time for FCH PET/CT. METHODS: This retrospective study included 73 patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shuang, Li, Mengdan, Pang, Hua, Zuo, Rui, Kong, Lingquan, Wang, Zhengjie, Li, Wenbo, Xia, Zhu, Wang, Dong, Xu, Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126393/
https://www.ncbi.nlm.nih.gov/pubmed/37113486
http://dx.doi.org/10.3389/fendo.2023.1100056
_version_ 1785030232861835264
author Liu, Shuang
Li, Mengdan
Pang, Hua
Zuo, Rui
Kong, Lingquan
Wang, Zhengjie
Li, Wenbo
Xia, Zhu
Wang, Dong
Xu, Lu
author_facet Liu, Shuang
Li, Mengdan
Pang, Hua
Zuo, Rui
Kong, Lingquan
Wang, Zhengjie
Li, Wenbo
Xia, Zhu
Wang, Dong
Xu, Lu
author_sort Liu, Shuang
collection PubMed
description OBJECTIVE: We evaluated the difference in parathyroid visualization on (18)F-FCH PET/CT images obtained at 5 and 60 min, and quantitatively analyzed the mode of FCH uptake at different time points, to determine the best imaging time for FCH PET/CT. METHODS: This retrospective study included 73 patients with hyperparathyroidism (HPT) who underwent (18)F-FCH PET/CT imaging between December 2017 and December 2021. The diagnostic efficiency of 5- and 60-min dual time point imaging for the diagnosis of hyperparathyroidism and parathyroid adenoma and hyperplasia, were compared using visual and quantitative analyses. RESULTS: Dual-time (18)F-FCH PET/CT imaging visual analysis had diagnostic value for HPT. The receiver operating characteristic curve of PET/CT quantitative parameters for the diagnosis of HPT and lesions showed that the parathyroid/thyroid SUVmax ratio for 60-min imaging had a higher sensitivity and specificity (based on patient, sensitivity: 90.90% and specificity: 85.71%; based on focus, sensitivity: 83.06% and specificity: 85.71%) compared to that for 5-min imaging. PET/CT quantitative parameters can distinguish parathyroid adenoma and hyperplasia. The 60-min parathyroid SUVmax value had the highest diagnostic value (cutoff: 3.945; area under the curve: 0.783). CONCLUSION: The quantitative parameters of 60min (18)F-FCH PET/CT have more advantages in aiding in the pathologica diagnosis and clinical treatment of HPT.
format Online
Article
Text
id pubmed-10126393
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101263932023-04-26 Clinical application of (18)F-FCH PET/CT in the diagnosis and treatment of hyperparathyroidism Liu, Shuang Li, Mengdan Pang, Hua Zuo, Rui Kong, Lingquan Wang, Zhengjie Li, Wenbo Xia, Zhu Wang, Dong Xu, Lu Front Endocrinol (Lausanne) Endocrinology OBJECTIVE: We evaluated the difference in parathyroid visualization on (18)F-FCH PET/CT images obtained at 5 and 60 min, and quantitatively analyzed the mode of FCH uptake at different time points, to determine the best imaging time for FCH PET/CT. METHODS: This retrospective study included 73 patients with hyperparathyroidism (HPT) who underwent (18)F-FCH PET/CT imaging between December 2017 and December 2021. The diagnostic efficiency of 5- and 60-min dual time point imaging for the diagnosis of hyperparathyroidism and parathyroid adenoma and hyperplasia, were compared using visual and quantitative analyses. RESULTS: Dual-time (18)F-FCH PET/CT imaging visual analysis had diagnostic value for HPT. The receiver operating characteristic curve of PET/CT quantitative parameters for the diagnosis of HPT and lesions showed that the parathyroid/thyroid SUVmax ratio for 60-min imaging had a higher sensitivity and specificity (based on patient, sensitivity: 90.90% and specificity: 85.71%; based on focus, sensitivity: 83.06% and specificity: 85.71%) compared to that for 5-min imaging. PET/CT quantitative parameters can distinguish parathyroid adenoma and hyperplasia. The 60-min parathyroid SUVmax value had the highest diagnostic value (cutoff: 3.945; area under the curve: 0.783). CONCLUSION: The quantitative parameters of 60min (18)F-FCH PET/CT have more advantages in aiding in the pathologica diagnosis and clinical treatment of HPT. Frontiers Media S.A. 2023-04-11 /pmc/articles/PMC10126393/ /pubmed/37113486 http://dx.doi.org/10.3389/fendo.2023.1100056 Text en Copyright © 2023 Liu, Li, Pang, Zuo, Kong, Wang, Li, Xia, Wang and Xu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Liu, Shuang
Li, Mengdan
Pang, Hua
Zuo, Rui
Kong, Lingquan
Wang, Zhengjie
Li, Wenbo
Xia, Zhu
Wang, Dong
Xu, Lu
Clinical application of (18)F-FCH PET/CT in the diagnosis and treatment of hyperparathyroidism
title Clinical application of (18)F-FCH PET/CT in the diagnosis and treatment of hyperparathyroidism
title_full Clinical application of (18)F-FCH PET/CT in the diagnosis and treatment of hyperparathyroidism
title_fullStr Clinical application of (18)F-FCH PET/CT in the diagnosis and treatment of hyperparathyroidism
title_full_unstemmed Clinical application of (18)F-FCH PET/CT in the diagnosis and treatment of hyperparathyroidism
title_short Clinical application of (18)F-FCH PET/CT in the diagnosis and treatment of hyperparathyroidism
title_sort clinical application of (18)f-fch pet/ct in the diagnosis and treatment of hyperparathyroidism
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126393/
https://www.ncbi.nlm.nih.gov/pubmed/37113486
http://dx.doi.org/10.3389/fendo.2023.1100056
work_keys_str_mv AT liushuang clinicalapplicationof18ffchpetctinthediagnosisandtreatmentofhyperparathyroidism
AT limengdan clinicalapplicationof18ffchpetctinthediagnosisandtreatmentofhyperparathyroidism
AT panghua clinicalapplicationof18ffchpetctinthediagnosisandtreatmentofhyperparathyroidism
AT zuorui clinicalapplicationof18ffchpetctinthediagnosisandtreatmentofhyperparathyroidism
AT konglingquan clinicalapplicationof18ffchpetctinthediagnosisandtreatmentofhyperparathyroidism
AT wangzhengjie clinicalapplicationof18ffchpetctinthediagnosisandtreatmentofhyperparathyroidism
AT liwenbo clinicalapplicationof18ffchpetctinthediagnosisandtreatmentofhyperparathyroidism
AT xiazhu clinicalapplicationof18ffchpetctinthediagnosisandtreatmentofhyperparathyroidism
AT wangdong clinicalapplicationof18ffchpetctinthediagnosisandtreatmentofhyperparathyroidism
AT xulu clinicalapplicationof18ffchpetctinthediagnosisandtreatmentofhyperparathyroidism